Deep Track Capital, LP Ultragenyx Pharmaceutical Inc. Transaction History
Deep Track Capital, LP
- $2.86 Billion
- Q1 2025
A detailed history of Deep Track Capital, LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 1,350,000 shares of RARE stock, worth $37.2 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
1,350,000
Previous 653,513
106.58%
Holding current value
$37.2 Million
Previous $27.5 Million
77.8%
% of portfolio
1.71%
Previous 1.21%
Shares
3 transactions
Others Institutions Holding RARE
# of Institutions
338Shares Held
89.4MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$275 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$154 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$115 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$88.6 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$72.1 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $1.93B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...